Heteromultivalent nanogels demonstrate over 99.9% inactivation of biofilm-associated infections, indicating new potential against antimicrobial resistance.
The increasing prevalence of microbial resistance requires new antibacterial concepts for selective targeting and killing of pathogenic bacteria. Here, we report the synthesis of a heteromultivalent nanogel system against Pseudomonas aeruginosa ( P. aeruginosa ). These nanogels are based on biocompatible polyglycerols and functionalized with sugar ligands fucose (Fuc) or galactose (Gal) for P. aeruginosa targeting. With a further modification of these nanogels with BMAP‐18 short chain peptides (GRFKRFRKKFKKLFKKLS), we have achieved > 99.99% inactivation of planktonic and > 99.9% inactivation of biofilm‐coated P. aeruginosa within 12 h of treatment. Additionally, the system demonstrates broad‐spectrum antimicrobial potential, effectively inhibiting Escherichia coli ( E. coli ) and Methicillin‐resistant Staphylococcus aureus (MRSA). This modular design offers a promising strategy for the development of next‐generation antimicrobial therapies targeting biofilm‐associated infections and MDR bacteria.
No takes yet. Share an insight, caveat, or question.
Jiang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: